Citations (124)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yiting Luo, Jin Wu, Yingchao Liu, Yan Shen, Fangyuan Zhu, Jiaqian Wu & Yuyao Hu. (2022) Metabolomics Study of Shaoyao Plants Decoction on the Proximal and Distal Colon in Mice with Dextran Sulfate Sodium-Induced Colitis by UPLC-Q-TOF-MS. Drug Design, Development and Therapy 16, pages 4343-4364.
Read now
Read now
Wolfgang Stremmel, Anja Hanemann, Annika Braun, Sabine Stoffels, Max Karner, Sahar Fazeli & Robert Ehehalt. (2010) Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis – a review of three clinical trials. Expert Opinion on Investigational Drugs 19:12, pages 1623-1630.
Read now
Read now
Luca Pastorelli, Theresa T Pizarro, Fabio Cominelli & Maurizio Vecchi. (2009) Emerging drugs for the treatment of ulcerative colitis. Expert Opinion on Emerging Drugs 14:3, pages 505-521.
Read now
Read now
Articles from other publishers (121)
Yueqi Hu, Yixin Suo, Yue Ma, Eric Marchioni, Li Zhou & Jikai Liu. (2024) Differentiation of lipid profiles of hen eggs from different regions based on lipidomics combined with chemometrics. Journal of Food Composition and Analysis 130, pages 106153.
Crossref
Crossref
Axel Dignass, Wolfgang Stremmel, Marek Horyński, Oleksandr Poyda, Peter Armerding, Klaus Fellermann, Jost Langhorst, Tanja Kuehbacher, Peter Uebel, Juergen Stein, Gottfried Novacek, Elena Avalueva, Oleksandr Oliinyk, Peter Hasselblatt, Andrey Dorofeyev, Heidrun Heinemann, Ralph Mueller, Roland Greinwald & Walter Reinisch. (2024) Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials. Clinical Gastroenterology and Hepatology 22:4, pages 810-820.e7.
Crossref
Crossref
Maria Questa, Bart C. Weimer, Oliver Fiehn, Betty Chow, Steve L. Hill, Mark R. Ackermann, Jonathan A. Lidbury, Joerg M. Steiner, Jan S. Suchodolski & Sina Marsilio. (2024) Unbiased serum metabolomic analysis in cats with naturally occurring chronic enteropathies before and after medical intervention. Scientific Reports 14:1.
Crossref
Crossref
Kai Zhang, Jianbin Ji, Nana Li, Zhaorui Yin & Guanwei Fan. (2023) Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition & Food Research 68:3.
Crossref
Crossref
Xi Fan, Zhuangzhuang Zhang, Wenxia Gao, Qingqing Pan, Kui Luo, Bin He & Yuji Pu. (2023) An Engineered Butyrate-Derived Polymer Nanoplatform as a Mucosa-Healing Enhancer Potentiates the Therapeutic Effect of Magnolol in Inflammatory Bowel Disease. ACS Nano 18:1, pages 229-244.
Crossref
Crossref
Meiling Liu, Siyi Guo & Liang Wang. (2024) Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways. Therapeutic Advances in Gastroenterology 17.
Crossref
Crossref
Jens Risbo, Tommy Nylander & Motomu Tanaka. (2023) Delivery of probiotics and enzymes in self-assemblies of lipids and biopolymers based on colloidal principles. Frontiers in Soft Matter 3.
Crossref
Crossref
Yunpeng Wen, Lixin Tan, Shuping Chen, Na Wu, Yao Yao, Lilan Xu, Mingsheng Xu, Yan Zhao & Yonggang Tu. (2023) Egg yolk phosphatidylcholine alleviates DSS-induced colitis in BALB/c mice. Food & Function 14:20, pages 9309-9323.
Crossref
Crossref
Jing Zhang, Ze Li, Ying Zhang, Yi-lei Guo, Yan-rong Zhu, Wen-xin Xia, Yue Dai & Yu-feng Xia. (2023) Mume Fructus (Prunus mume Sieb. et Zucc.) extract accelerates colonic mucosal healing of mice with colitis induced by dextran sulfate sodium through potentiation of cPLA2-mediated lysophosphatidylcholine synthesis. Phytomedicine 119, pages 154985.
Crossref
Crossref
Hisako Kayama & Kiyoshi Takeda. (2023) Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases. European Journal of Immunology 53:8.
Crossref
Crossref
Tengjie Yu, Linlin Wu, Tingting Zhang, Hongyuan Hao, Jing Dong, Yexin Xu, Huizhu Yang, Huafang Liu, Lin Xie, Guangji Wang & Yan Liang. (2023) Insights into Q-markers and molecular mechanism of Sanguisorba saponins in treating ulcerative colitis based on lipid metabolism regulation. Phytomedicine 116, pages 154870.
Crossref
Crossref
Yingzheng Zhao, Jiawei Xu, Jianxun Shangguan, Hanxiao Pan, Kaili Lu, Sunkuan Hu & Helin Xu. (2023) In situ gel-forming oil as rectally delivering platform of hydrophobic therapeutics for ulcerative colitis therapy. International Journal of Pharmaceutics 642, pages 123149.
Crossref
Crossref
Nousayhah Amdanee, Miaomiao Shao, Xiuxiu Hu, Xinyu Fang, Chao Zhou, Jiu Chen, Mohammad Ridwan Chattun, Lu Wen, Xinming Pan, Xiangrong Zhang & Yue Xu. (2023) Serum Metabolic Profile in Schizophrenia Patients With Antipsychotic-Induced Constipation and Its relationship With Gut Microbiome. Schizophrenia Bulletin 49:3, pages 646-658.
Crossref
Crossref
Desmond Owusu Kwarteng, Mahinda Gangoda & Edgar E. Kooijman. (2023) The effect of methylated phosphatidylethanolamine derivatives on the ionization properties of signaling phosphatidic acid. Biophysical Chemistry 296, pages 107005.
Crossref
Crossref
Mia Øgaard Mønsted, Mesut Bilgin, Marek Kuzma, Helena Pelantová, Kristina Pedersen, Petra Tomášová, Anastasiia Nazmutdinova, Blanka Šedivá, David Funda, Josué L. Castro‐Mejía, Laurits Juulskov Holm, Dennis Sandris Nielsen & Martin Haupt‐Jorgensen. (2023) Reduced phosphatidylcholine level in the intestinal mucus layer of prediabetic NOD mice. APMIS.
Crossref
Crossref
Tengjie Yu, Zhihao Zhou, Shijia Liu, Changjian Li, Zhi-Wei Zhang, Yong Zhang, Wei Jin, Keanqi Liu, Shuying Mao, Lei Zhu, Lin Xie, Guangji Wang & Yan Liang. (2023) The role of phosphatidylcholine 34:1 in the occurrence, development and treatment of ulcerative colitis. Acta Pharmaceutica Sinica B 13:3, pages 1231-1245.
Crossref
Crossref
Raktim Ghosh, Suchetana Pal, Subhasish Sarkar & Somasri Dam. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology
9
33
.
Agathi Thomaidou, Olga Deda, Olga Begou, Artemis Lioupi, Angeliki Kontou, Helen Gika, Eleni Agakidou, Georgios Theodoridis & Kosmas Sarafidis. (2022) A Prospective, Case-Control Study of Serum Metabolomics in Neonates with Late-Onset Sepsis and Necrotizing Enterocolitis. Journal of Clinical Medicine 11:18, pages 5270.
Crossref
Crossref
Yuriko Otake-Kasamoto, Hisako Kayama, Toshihiro Kishikawa, Shinichiro Shinzaki, Taku Tashiro, Takahiro Amano, Mizuki Tani, Takeo Yoshihara, Bo Li, Haruka Tani, Li Liu, Akio Hayashi, Daisuke Okuzaki, Daisuke Motooka, Shota Nakamura, Yukinori Okada, Hideki Iijima, Kiyoshi Takeda & Tetsuo Takehara. (2022) Lysophosphatidylserines derived from microbiota in Crohn’s disease elicit pathological Th1 response. Journal of Experimental Medicine 219:7.
Crossref
Crossref
Wolfgang Stremmel, Hüseyin Vural, Osman Evliyaoglu & Ralf Weiskirchen. (2022) Wirksamkeit von darmlöslichem Lecithin (Phosphatidylcholin) zur Behandlung der Colitis ulcerosaEfficacy of enteric lecithin (phosphatidylcholine) in the treatment of ulcerative colitis: a meta-analysis. MMW - Fortschritte der Medizin 164:S7, pages 3-11.
Crossref
Crossref
Cui Liu, Xiangji Yan, Yujie Zhang, Mei Yang, Yana Ma, Yuanyuan Zhang, Qiuran Xu, Kangsheng Tu & Mingzhen Zhang. (2022) Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Christine M. Madla, Francesca K. H. Gavins, Sarah J. Trenfield & Abdul W. Basit. 2022. Biopharmaceutics. Biopharmaceutics
205
237
.
Giorgos Bamias & Fabio Cominelli. (2021) Exploring the Early Phase of Crohn’s Disease. Clinical Gastroenterology and Hepatology 19:12, pages 2469-2480.
Crossref
Crossref
Julia Kleetz, Georgios Vasilopoulos, Simon Czolkoss, Meriyem Aktas & Franz Narberhaus. (2021) Recombinant and endogenous ways to produce methylated phospholipids in Escherichia coli. Applied Microbiology and Biotechnology 105:23, pages 8837-8851.
Crossref
Crossref
Eun Goo Lee, Young Cheol Yoon, Jihyun Yoon, Seul Ji Lee, Yu-Kyoung Oh & Sung Won Kwon. (2021) Systematic Review of Recent Lipidomics Approaches Toward Inflammatory Bowel Disease. Biomolecules & Therapeutics 29:6, pages 582-595.
Crossref
Crossref
Lidiya V. Boldyreva, Maryana V. Morozova, Snezhanna S. Saydakova & Elena N. Kozhevnikova. (2021) Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. International Journal of Molecular Sciences 22:21, pages 11682.
Crossref
Crossref
José Miranda-Bautista, Juan A Rodríguez-Feo, Marta Puerto, Beatriz López-Cauce, José M Lara, Raquel González-Novo, David Martín-Hernández, Rocío Ferreiro-Iglesias, Rafael Bañares & Luis Menchén. (2021)
Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via
ABCA1
and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease
. Inflammatory Bowel Diseases 27:10, pages 1661-1673.
Crossref
Crossref
Jacob T. Bjerrum, Yulan L. Wang, Jakob B. Seidelin & Ole H. Nielsen. (2021) IBD metabonomics predicts phenotype, disease course, and treatment response. eBioMedicine 71, pages 103551.
Crossref
Crossref
Varsha Komalla, Meenu Mehta, Fatima Achi, Kamal Dua & Mehra Haghi. (2021) The Potential for Phospholipids in the Treatment of Airway Inflammation: An Unexplored Solution. Current Molecular Pharmacology 14:3, pages 333-349.
Crossref
Crossref
Justyna Kikut, Nina Konecka, Maciej Ziętek, Danuta Kulpa & Małgorzata Szczuko. (2021) Diet supporting therapy for inflammatory bowel diseases. European Journal of Nutrition 60:5, pages 2275-2291.
Crossref
Crossref
Leila B. Giron, Harsh Dweep, Xiangfan Yin, Han Wang, Mohammad Damra, Aaron R. Goldman, Nicole Gorman, Clovis S. Palmer, Hsin-Yao Tang, Maliha W. Shaikh, Christopher B. Forsyth, Robert A. Balk, Netanel F. Zilberstein, Qin Liu, Andrew Kossenkov, Ali Keshavarzian, Alan Landay & Mohamed Abdel-Mohsen. (2021) Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Frontiers in Immunology 12.
Crossref
Crossref
Abigail Raffner Basson, Saleh Ahmed, Rawan Almutairi, Brian Seo & Fabio Cominelli. (2021) Regulation of Intestinal Inflammation by Soybean and Soy-Derived Compounds. Foods 10:4, pages 774.
Crossref
Crossref
Mireille Alhouayek, Hafsa Ameraoui & Giulio G. Muccioli. (2021) Bioactive lipids in inflammatory bowel diseases – From pathophysiological alterations to therapeutic opportunities. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1866:2, pages 158854.
Crossref
Crossref
Tingting Ju, John P. Kennelly, René L. Jacobs & Benjamin P. Willing. (2020)
Insufficient dietary choline aggravates disease severity in a mouse model of
Citrobacter rodentium
-induced colitis
. British Journal of Nutrition 125:1, pages 50-61.
Crossref
Crossref
Wolfgang Stremmel, Hüseyin Vural, Osman Evliyaoglu & Ralf Weiskirchen. (2021) Delayed-Release Phosphatidylcholine Is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis. Digestive Diseases 39:5, pages 508-515.
Crossref
Crossref
John P. Kennelly, Stephanie Carlin, Tingting Ju, Jelske N. van der Veen, Randal C. Nelson, Jean Buteau, Aducio Thiesen, Caroline Richard, Ben P. Willing & René L. Jacobs. (2021) Intestinal Phospholipid Disequilibrium Initiates an ER Stress Response That Drives Goblet Cell Necroptosis and Spontaneous Colitis in Mice. Cellular and Molecular Gastroenterology and Hepatology 11:4, pages 999-1021.
Crossref
Crossref
Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna & Alessandra Miccono. (2021) A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinología, Diabetes y Nutrición 68:1, pages 17-46.
Crossref
Crossref
Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna & Alessandra Miccono. (2021) A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinología, Diabetes y Nutrición (English ed.) 68:1, pages 17-46.
Crossref
Crossref
Martha M Liu, Shannon Coleman, Lauren Wilkinson, Maren L Smith, Thomas Hoang, Naomi Niyah, Manjari Mukherjee, Steven Huynh, Craig T Parker, Jasna Kovac, Robert E W Hancock & Erin C Gaynor. (2020)
Unique inducible filamentous motility identified in pathogenic
Bacillus cereus
group species
. The ISME Journal 14:12, pages 2997-3010.
Crossref
Crossref
Lixiang Zhai, Tao Huang, Hai-tao Xiao, Pei-gen Wu, Cheng-yuan Lin, Zi-wan Ning, Ling Zhao, Hiu Yee Anna Kwan, Xian-jing Hu, Hoi Leong Xavier Wong, Xian-qian Li & Zhao-xiang Bian. (2020) Berberine Suppresses Colonic Inflammation in Dextran Sulfate Sodium–Induced Murine Colitis Through Inhibition of Cytosolic Phospholipase A2 Activity. Frontiers in Pharmacology 11.
Crossref
Crossref
Jie Shen, Pei Li, Shuangshuang Liu, Qing Liu, Yue Li, Zheng Zhang, Chengmin Yang, Mengying Hu, Yuhua Sun, Chunnian He & Peigen Xiao. (2020) The chemopreventive effects of Huangqin-tea against AOM-induced preneoplastic colonic aberrant crypt foci in rats and omics analysis. Food & Function 11:11, pages 9634-9650.
Crossref
Crossref
Yunyue Zhang, Maya Thanou & Driton Vllasaliu. (2020) Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. European Journal of Pharmaceutics and Biopharmaceutics 155, pages 128-138.
Crossref
Crossref
Serena Longo, Marcello Chieppa, Luca G. Cossa, Chiara C. Spinelli, Marco Greco, Michele Maffia & Anna M. Giudetti. (2020) New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies. Proteomes 8:3, pages 18.
Crossref
Crossref
Mahyar Taghavizadeh, Seyed Pezhman Hosseini Shekarabi, Mehdi Shamsaie Mehrgan & Houman Rajabi Islami. (2020) Efficacy of dietary lysophospholipids (Lipidol™) on growth performance, serum immuno-biochemical parameters, and the expression of immune and antioxidant-related genes in rainbow trout (Oncorhynchus mykiss). Aquaculture 525, pages 735315.
Crossref
Crossref
Nanhai Xiao, Yan Zhao, Yao Yao, Na Wu, Mingsheng Xu, Huaying Du & Yonggang Tu. (2020) Biological Activities of Egg Yolk Lipids: A Review. Journal of Agricultural and Food Chemistry 68:7, pages 1948-1957.
Crossref
Crossref
Joseph Diab, Terkel Hansen, Rasmus Goll, Hans Stenlund, Maria Ahnlund, Einar Jensen, Thomas Moritz, Jon Florholmen & Guro Forsdahl. (2019) Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State. Inflammatory Bowel Diseases 25:11, pages 1780-1787.
Crossref
Crossref
Wolfgang Stremmel, Simone Staffer & Ralf Weiskirchen. (2019) Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1. International Journal of Molecular Sciences 20:16, pages 4034.
Crossref
Crossref
Urszula Daniluk, Jaroslaw Daniluk, Rafal Kucharski, Tomasz Kowalczyk, Karolina Pietrowska, Paulina Samczuk, Aleksandra Filimoniuk, Adam Kretowski, Dariusz Lebensztejn & Michal Ciborowski. (2019) Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn’s Disease and Ulcerative Colitis—A Preliminary Study. Inflammatory Bowel Diseases 25:7, pages 1120-1128.
Crossref
Crossref
G. Brett Moreau, Girija Ramakrishnan, Heather L. Cook, Todd E. Fox, Uma Nayak, Jennie Z. Ma, E. Ross Colgate, Beth D. Kirkpatrick, Rashidul Haque & William A. PetriJrJr. (2019) Childhood growth and neurocognition are associated with distinct sets of metabolites. EBioMedicine 44, pages 597-606.
Crossref
Crossref
Angela Effinger, Caitriona M O'Driscoll, Mark McAllister & Nikoletta Fotaki. (2019) Impact of gastrointestinal disease states on oral drug absorption – implications for formulation design – a PEARRL review. Journal of Pharmacy and Pharmacology 71:4, pages 674-698.
Crossref
Crossref
Silvia Torrecillas, Daniel Montero, David Domínguez, Lidia Robaina & Marisol Izquierdo. (2019) Skin Mucus Fatty Acid Composition of Gilthead Sea Bream (Sparus Aurata): A Descriptive Study in Fish Fed Low and High Fish Meal Diets. Fishes 4:1, pages 15.
Crossref
Crossref
Maryam Eshrati, Federico Amadei, Simone Staffer, Wolfgang Stremmel & Motomu Tanaka. (2018)
Shear-Enhanced Dynamic Adhesion of
Lactobacillus rhamnosus
GG on Intestinal Epithelia: Correlative Effect of Protein Expression and Interface Mechanics
. Langmuir 35:2, pages 529-537.
Crossref
Crossref
Philipp Schreiner, Markus F. Neurath, Siew C. Ng, Emad M. El-Omar, Ala I. Sharara, Taku Kobayashi, Tadakazu Hisamatsu, Toshifumi Hibi & Gerhard Rogler. (2019) Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More. Inflammatory Intestinal Diseases 4:3, pages 79-96.
Crossref
Crossref
Elisabetta Antonelli, Vincenzo Villanacci & Gabrio Bassotti. (2018) Novel oral-targeted therapies for mucosal healing in ulcerative colitis. World Journal of Gastroenterology 24:47, pages 5322-5330.
Crossref
Crossref
Roni Weisshof, Katia El Jurdi, Nada Zmeter & David T. Rubin. (2018) Emerging Therapies for Inflammatory Bowel Disease. Advances in Therapy 35:11, pages 1746-1762.
Crossref
Crossref
Na Sun, Jin Chen, Di Wang & Songyi Lin. (2018) Advance in food-derived phospholipids: Sources, molecular species and structure as well as their biological activities. Trends in Food Science & Technology 80, pages 199-211.
Crossref
Crossref
Antonio Murgia, Christine Hinz, Sonia Liggi, Jùlìa Denes, Zoe Hall, James West, Maria Laura Santoru, Cristina Piras, Cristina Manis, Paolo Usai, Luigi Atzori, Julian L. Griffin & Pierluigi Caboni. (2018) Italian cohort of patients affected by inflammatory bowel disease is characterised by variation in glycerophospholipid, free fatty acids and amino acid levels. Metabolomics 14:10.
Crossref
Crossref
Bjoern Titz, Raffaella Gadaleta, Giuseppe Lo Sasso, Ashraf Elamin, Kim Ekroos, Nikolai Ivanov, Manuel Peitsch & Julia Hoeng. (2018) Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification. International Journal of Molecular Sciences 19:9, pages 2775.
Crossref
Crossref
Grace B. Hatton, Christine M. Madla, Sarit C. Rabbie & Abdul W. Basit. (2018) All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance. International Journal of Pharmaceutics 548:1, pages 408-422.
Crossref
Crossref
Anthony F Juritsch & Régis Moreau. (2018) Role of soybean-derived bioactive compounds in inflammatory bowel disease. Nutrition Reviews 76:8, pages 618-638.
Crossref
Crossref
Alyssa M. Parian, Gerard E. Mullin, Jost Langhorst & Amy C. Brown. 2018. Integrative Medicine. Integrative Medicine
501
516.e8
.
Marcel Vetter & Markus F. Neurath. (2017) Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges. Therapeutic Advances in Gastroenterology 10:10, pages 773-790.
Crossref
Crossref
Wolfgang Stremmel, Simone Staffer, Mathias Jochen Schneider, Hongying Gan-Schreier, Andreas Wannhoff, Nicole Stuhrmann, Annika Gauss, Hartwig Wolburg, Anne Mahringer, Alexander Swidsinski & Thomas Efferth. (2017) Genetic Mouse Models with Intestinal-Specific Tight Junction Deletion Resemble an Ulcerative Colitis Phenotype. Journal of Crohn's and Colitis 11:10, pages 1247-1257.
Crossref
Crossref
Hao Ding, Andrew W. Dupont, Shashideep Singhal, Larry D. Scott, Sushovan Guha, Mamoun Younes & Xiaohong Bi. (2017) In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy. Biomedical Optics Express 8:7, pages 3426.
Crossref
Crossref
Katharina F. Hermann, Claudia S. Neuhaus, Virgine Micallef, Björn Wagner, Maja Hatibovic, Hélène E. Aschmann, Franziska Paech, Rubén Alvarez-Sanchez, Stefanie D. Krämer & Sara Belli. (2017) Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability. European Journal of Pharmaceutical Sciences 104, pages 150-161.
Crossref
Crossref
Agatha Korytowski, Wasim Abuillan, Federico Amadei, Ali Makky, Andrea Gumiero, Irmgard Sinning, Annika Gauss, Wolfgang Stremmel & Motomu Tanaka. (2017) Accumulation of phosphatidylcholine on gut mucosal surface is not dominated by electrostatic interactions. Biochimica et Biophysica Acta (BBA) - Biomembranes 1859:5, pages 959-965.
Crossref
Crossref
L.R. Fitzpatrick & T. Woldemariam. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
495
510
.
Joel Pekow. 2017. Inflammatory Bowel Disease. Inflammatory Bowel Disease
183
204
.
Neeraj Narula, David T Rubin & Bruce E Sands. (2016) Novel Therapies in Inflammatory Bowel Disease: An Evaluation of the Evidence. The American Journal of Gastroenterology Supplements 3:3, pages 38-44.
Crossref
Crossref
Silvia Turroni, Jessica Fiori, Simone Rampelli, Stephanie L. Schnorr, Clarissa Consolandi, Monica Barone, Elena Biagi, Flaminia Fanelli, Marco Mezzullo, Alyssa N. Crittenden, Amanda G. Henry, Patrizia Brigidi & Marco Candela. (2016) Fecal metabolome of the Hadza hunter-gatherers: a host-microbiome integrative view. Scientific Reports 6:1.
Crossref
Crossref
Wolfgang Stremmel, Simone Staffer, Hongying Gan-Schreier, Andreas Wannhoff, Margund Bach & Annika Gauss. (2016) Phosphatidylcholine passes through lateral tight junctions for paracellular transport to the apical side of the polarized intestinal tumor cell-line CaCo2. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1861:9, pages 1161-1169.
Crossref
Crossref
S. Courtney Frasch, Eóin N. McNamee, Douglas Kominsky, Paul Jedlicka, Claudia Jakubzick, Karin Zemski Berry, Matthias Mack, Glenn T. Furuta, James J. Lee, Peter M. Henson, Sean P. Colgan & Donna L. Bratton. (2016) G2A Signaling Dampens Colitic Inflammation via Production of IFN-γ. The Journal of Immunology 197:4, pages 1425-1434.
Crossref
Crossref
Giorgos Bamias, Theresa T. Pizarro & Fabio Cominelli. (2016) Pathway-based approaches to the treatment of inflammatory bowel disease. Translational Research 167:1, pages 104-115.
Crossref
Crossref
Li Jiao, Johannes Inhoffen, Hongying Gan-Schreier, Sabine Tuma-Kellner, Wolfgang Stremmel, Zhiwei Sun & Walee Chamulitrat. (2015) Deficiency of Group VIA Phospholipase A2 (iPLA2β) Renders Susceptibility for Chemical-Induced Colitis. Digestive Diseases and Sciences 60:12, pages 3590-3602.
Crossref
Crossref
Catherine Andersen. (2015) Bioactive Egg Components and Inflammation. Nutrients 7:9, pages 7889-7913.
Crossref
Crossref
Steven K. Huang & Marc Peters-Golden. (2015) Prostaglandin E2 and Polyenylphosphatidylcholine: Stiff Competition for the Fibrotic Complications of Inflammatory Bowel Disease?. Digestive Diseases and Sciences 60:6, pages 1514-1516.
Crossref
Crossref
Angela C. Baird, Frances Lloyd & Ian C. Lawrance. (2015) Prostaglandin E2 and Polyenylphosphatidylcholine Protect Against Intestinal Fibrosis and Regulate Myofibroblast Function. Digestive Diseases and Sciences 60:6, pages 1603-1616.
Crossref
Crossref
Dana Ben-Ami Shor, Tomer Bashi, Jordan Lachnish, Mati Fridkin, Giorgia Bizzaro, Iris Barshak, Miri Blank & Yehuda Shoenfeld. (2015) Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: Implications for the treatment of human inflammatory bowel disease. Journal of Autoimmunity 56, pages 111-117.
Crossref
Crossref
Julie M. Davies, Hong-Uyen Hua, Rishu Dheer, Mitchell Martinez, Sanjoy K. Bhattacharya & Maria T. Abreu. (2014) Stool Phospholipid Signature is Altered by Diet and Tumors. PLoS ONE 9:12, pages e114352.
Crossref
Crossref
S. Schreiber, S. Nikolaus & P. Rosenstiel. (2014) Mikrobiom und ErnährungMicrobiome and nutrition. Der Internist 55:8, pages 889-897.
Crossref
Crossref
Peter DR Higgins. (2014) Editorial: The IBD Drug Pipeline—Ready to Deliver?. American Journal of Gastroenterology 109:7, pages 1052-1054.
Crossref
Crossref
Max Karner, Andreas Kocjan, Juergen Stein, Stefan Schreiber, Georg von Boyen, Peter Uebel, Carsten Schmidt, Limas Kupcinskas, Ion Dina, Frank Zuelch, Gerhard Keilhauer & Wolfgang Stremmel. (2014) First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses. American Journal of Gastroenterology 109:7, pages 1041-1051.
Crossref
Crossref
G. W. Moran, M. F. Dubeau, G. G. Kaplan, R. Panaccione & S. Ghosh. (2014) Novel concepts in inflammatory bowel disease. British Medical Bulletin 109:1, pages 55-72.
Crossref
Crossref
Joana Torres, Silvio Danese & Jean-Frédéric Colombel. (2013) New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut 62:11, pages 1642-1652.
Crossref
Crossref
Aleksander Krag, Pia Munkholm, Hans Israelsen, Bjørn von Ryberg, Klaus K. Andersen & Flemming Bendtsen. (2013) Profermin is Efficacious in Patients with Active Ulcerative Colitis—A Randomized Controlled Trial. Inflammatory Bowel Diseases 19:12, pages 2584-2592.
Crossref
Crossref
Lenard M. Lichtenberger. (2013) Role of Phospholipids in Protection of the GI Mucosa. Digestive Diseases and Sciences 58:4, pages 891-893.
Crossref
Crossref
Wolfgang Stremmel & Annika Gauss. (2013) Lecithin as a Therapeutic Agent in Ulcerative Colitis. Digestive Diseases 31:3-4, pages 388-390.
Crossref
Crossref
S. Nuding, L. Antoni & E.F. Stange. (2013) The Host and the Flora. Digestive Diseases 31:3-4, pages 286-292.
Crossref
Crossref
A. Christy Hunter, Jacqueline Elsom, Peter P. Wibroe & S. Moein Moghimi. (2012) Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomedicine: Nanotechnology, Biology and Medicine 8, pages S5-S20.
Crossref
Crossref
A. Christy Hunter, Jacqueline Elsom, Peter P. Wibroe & S. Moein Moghimi. (2012) Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective. Maturitas 73:1, pages 5-18.
Crossref
Crossref
Tamás Kovács, Gabriella VargaDániel ÉrcesTünde TőkésLászló Tiszlavicz, Miklós GhyczyLászló Vécsei, Mihály BorosJózsef Kaszaki. (2012) Terápiás lehetőségek a gyulladásos bélbetegség állatkísérletes modelljében – összehasonlító vizsgálat. Magyar Sebészet 65:4, pages 191-197.
Crossref
Crossref
Tamás Kovács, Gabriella Varga, Dániel Érces, Tünde Tőkés, László Tiszlavicz, Miklós Ghyczy, Mihály Boros & József Kaszaki. (2012) Dietary Phosphatidylcholine Supplementation Attenuates Inflammatory Mucosal Damage in a Rat Model of Experimental Colitis. Shock 38:2, pages 177-185.
Crossref
Crossref
Martin J. Wolff, Mara J. Broadhurst & P’ng Loke. (2012) Helminthic therapy: improving mucosal barrier function. Trends in Parasitology 28:5, pages 187-194.
Crossref
Crossref
Laura M. Ensign, Richard Cone & Justin Hanes. (2012) Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Advanced Drug Delivery Reviews 64:6, pages 557-570.
Crossref
Crossref
Darla R. Shores, David G. Binion, Bruce A. Freeman & Paul R.S. Baker. (2011) New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. Inflammatory Bowel Diseases 17:10, pages 2192-2204.
Crossref
Crossref
Annika Braun, Ulrike Schönfeld, Thilo Welsch, Martina Kadmon, Benjamin Funke, Daniel Gotthardt, Alexandra Zahn, Frank Autschbach, Peter Kienle, Michael Zharnikov, Michael Grunze, Wolfgang Stremmel & Robert Ehehalt. (2011) Reduced hydrophobicity of the colonic mucosal surface in ulcerative colitis as a hint at a physicochemical barrier defect. International Journal of Colorectal Disease 26:8, pages 989-998.
Crossref
Crossref
Manami Inoue, Mika Adachi, Yoshibumi Shimizu, Toshihiko Tsutsumi & Akira Tokumura. (2011) Comparison of Lysophospholipid Levels in Rat Feces with Those in a Standard Chow. Journal of Agricultural and Food Chemistry 59:13, pages 7062-7067.
Crossref
Crossref
Michal Markiewicz & Marta Pasenkiewicz-Gierula. (2011) Comparative Model Studies of Gastric Toxicity of Nonsteroidal Anti-Inflammatory Drugs. Langmuir 27:11, pages 6950-6961.
Crossref
Crossref
Hannah Schneider, Annika Braun, Joachim Füllekrug, Wolfgang Stremmel & Robert Ehehalt. (2010) Lipid Based Therapy for Ulcerative Colitis—Modulation of Intestinal Mucus Membrane Phospholipids as a Tool to Influence Inflammation. International Journal of Molecular Sciences 11:10, pages 4149-4164.
Crossref
Crossref
Robert Ehehalt, Annika Braun, Max Karner, Joachim Füllekrug & Wolfgang Stremmel. (2010) Phosphatidylcholine as a constituent in the colonic mucosal barrier—Physiological and clinical relevance. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1801:9, pages 983-993.
Crossref
Crossref
Elizabeth J. Dial, Duy M. Tran, Jimmy J. Romero, Mayssa Zayat & Lenard M. Lichtenberger. (2010) A DIRECT ROLE FOR SECRETORY PHOSPHOLIPASE A2 AND LYSOPHOSPHATIDYLCHOLINE IN THE MEDIATION OF LPS-INDUCED GASTRIC INJURY. Shock 33:6, pages 634-638.
Crossref
Crossref
Wolfgang Stremmel, Annika Braun, Anja Hanemann, Robert Ehehalt, Frank Autschbach & Max Karner. (2010) Delayed Release Phosphatidylcholine in Chronic-active Ulcerative Colitis. Journal of Clinical Gastroenterology 44:5, pages e101-e107.
Crossref
Crossref
Byron L. Sparkes, Emily E. Archer Slone, Mary Roth, Ruth Welti & Sherry D. Fleming. (2010) Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1801:4, pages 517-525.
Crossref
Crossref
Paola D’Arrigo & Stefano Servi. (2010) Synthesis of Lysophospholipids. Molecules 15:3, pages 1354-1377.
Crossref
Crossref
Zhenwen Zhao & Yan Xu. (2010) An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples. Journal of Lipid Research 51:3, pages 652-659.
Crossref
Crossref
Irina Treede, Annika Braun, Petia Jeliaskova, Thomas Giese, Joachim Füllekrug, Gareth Griffiths, Wolfgang Stremmel & Robert Ehehalt. (2009) TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterology 9:1.
Crossref
Crossref
Zhenwen Zhao & Yan Xu. (2009) Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine. Journal of Chromatography B 877:29, pages 3739-3742.
Crossref
Crossref
Annika Braun, Irina Treede, Daniel Gotthardt, Anke Tietje, Alexandra Zahn, Rebecca Ruhwald, Ulrike Schoenfeld, Thilo Welsch, Peter Kienle, Gerhard Erben, Wolf-Dieter Lehmann, Joachim Fuellekrug, Wolfgang Stremmel & Robert Ehehalt. (2009) Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis. Inflammatory Bowel Diseases 15:11, pages 1705-1720.
Crossref
Crossref
LM Lichtenberger, JJ Romero & EJ Dial. (2009) Gastrointestinal safety and therapeutic efficacy of parenterally administered phosphatidylcholine‐associated indomethacin in rodent model systems. British Journal of Pharmacology 157:2, pages 252-257.
Crossref
Crossref
Daniel Gotthardt, Annika Braun, Anke Tietje, Karl Heinz Weiss, Robert Ehehalt & Wolfgang R Stremmel. (2009) Separate basolateral and apical phosphatidylcholinesecretion routes in intestinally differentiated tumor cells. World Journal of Gastroenterology 15:46, pages 5821.
Crossref
Crossref
Anthony D. Postle. (2009) Phospholipid lipidomics in health and disease. European Journal of Lipid Science and Technology 111:1, pages 2-13.
Crossref
Crossref
Jessica R. Nealon, Stephen J. Blanksby, Sarah K. Abbott, A.J. Hulbert, Todd W. Mitchell & Roger J.W. Truscott. (2008) Phospholipid composition of the rat lens is independent of diet. Experimental Eye Research 87:6, pages 502-514.
Crossref
Crossref
Jane M. Deeley, Todd W. Mitchell, Xiaojia Wei, John Korth, Jessica R. Nealon, Stephen J. Blanksby & Roger J.W. Truscott. (2008) Human lens lipids differ markedly from those of commonly used experimental animals. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1781:6-7, pages 288-298.
Crossref
Crossref
W. E. W. ROEDIGER. (2008) Review article: nitric oxide from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis. Alimentary Pharmacology & Therapeutics 27:7, pages 531-541.
Crossref
Crossref
ANDREAS UPHOFF, MARTIN HERMANSSON, PERTTU HAIMI & PENTTI SOMERHARJU. 2008. Medical Applications of Mass Spectrometry. Medical Applications of Mass Spectrometry
223
249
.
Irina Treede, Annika Braun, Richard Sparla, Mark Kühnel, Thomas Giese, Jerrold R. Turner, Elsa Anes, Hasan Kulaksiz, Joachim Füllekrug, Wolfgang Stremmel, Gareth Griffiths & Robert Ehehalt. (2007) Anti-inflammatory Effects of Phosphatidylcholine. Journal of Biological Chemistry 282:37, pages 27155-27164.
Crossref
Crossref
M. Karner, R. Ehehalt & W. Stremmel. 2007. Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation. Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation
161
170
.
Shiu-Ying Ho, Kristin Lorent, Michael Pack & Steven A. Farber. (2006) Zebrafish fat-free is required for intestinal lipid absorption and Golgi apparatus structure. Cell Metabolism 3:4, pages 289-300.
Crossref
Crossref
Susanne Heimerl, Christoph Moehle, Alexandra Zahn, Alfred Boettcher, Wolfgang Stremmel, Thomas Langmann & Gerd Schmitz. (2006) Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:3, pages 341-350.
Crossref
Crossref
Brianna L. Peterson & Brian S. Cummings. (2005) A review of chromatographic methods for the assessment of phospholipids in biological samples. Biomedical Chromatography 20:3, pages 227-243.
Crossref
Crossref
. (2005) Current literature in mass spectrometry. Journal of Mass Spectrometry 40:2, pages 277-288.
Crossref
Crossref